|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | -40.00% |
|
0.00% | -62.50% |
| 05-25 | Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-30 | Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | |||||||||
Pharmaceuticals | 225K | 138K | 61.93K | 113K | 67.89K | ||||
Total Assets | 770K | 105K | 76.89K | 63.9K | 82.82K | ||||
Interest Expense | - | -588 | -31.08K | -49.93K | -50.36K | ||||
CAPEX | - | - | - | - | - | ||||
EBT | -2.39M | -794K | -813K | -456K | -631K | ||||
Gross Profit | 188K | 135K | 54.1K | 85.72K | 58.07K | ||||
D&A | 8.02K | 6.73K | 3.24K | 2.12K | - | ||||
Operating Income | - | - | - | - | - | ||||
Net Income | -2.39M | -794K | -813K | -456K | -631K |
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
United States | - | 137K | 28.19K | 113K | 67.88K | ||||
Total Assets | - | 5.5K | 2.2K | - | - | ||||
Canada | 225K | 1.21K | 33.74K | - | - | ||||
Total Assets | 770K | - | - | - | - | ||||
Interest Expense | - | - | - | - | - | ||||
D&A | 8.02K | - | - | - | - | ||||
CAPEX | - | - | - | - | - | ||||
Gross Profit | 188K | - | - | - | - | ||||
Net Income | -2.39M | - | - | - | - | ||||
EBT | -2.39M | - | - | - | - | ||||
Operating Income | - | - | - | - | - |
- Stock Market
- Stocks
- OVAT Stock
- Financials Ovation Science Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
